Korro Bio KRRO
NASDAQ KRRO
$9.71 -0.20 (-2.02%)
At close: Oct 1, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Cash from Financing Activities (2018 - 2026)

Updated

Korro Bio (KRRO) reported Cash from Financing Activities of -$2.92 million for Q2 2026, compared with $5,000 a year earlier.

Analysis

Korro Bio (KRRO) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Korro Bio's Cash from Financing Activities came in at $85.8 million; for FY2025, it came in at $685,000, down 99.0% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of -58.7% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $69.36 million in FY2024 (-63.1%), $187.76 million in FY2023, $18,000 in FY2022 (-98.7%) and $1.36 million in FY2021 (-97.6%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities in data going back to Q4 2018.
  • Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 63.5%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q1 2025 (growth of 23.7%); the low point was Q2 2025 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $88.21 million (Q1 2026), $380,000 (Q4 2025) and $128,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Korro Bio 145.73 Mn -250.91 Mn - -2.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.92 Mn
Mar 31, 2026 88.21 Mn
Dec 31, 2025 380,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 172,000.00
Dec 31, 2024 932,000.00
Sep 30, 2024 728,000.00
Jun 30, 2024 67.56 Mn
Mar 31, 2024 139,000.00
Dec 31, 2023 144.59 Mn
Sep 30, 2023 -2.19 Mn
Jun 30, 2023 -36,000.00
Mar 31, 2023 45.40 Mn
Dec 31, 2022 -238,000.00
Sep 30, 2022 56,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 109,000.00
Sep 30, 2021 349,000.00
Jun 30, 2021 328,000.00
API Access

Korro Bio Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KRRO&period=max&api_key=YOUR_API_KEY